Renaissance Technologies - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 3 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 2.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$96
-92.3%
30,282
-88.0%
0.00%
-100.0%
Q2 2023$1,252
-40.9%
251,900
-41.2%
0.00%
-33.3%
Q1 2023$2,118
-23.5%
428,700
-2.6%
0.00%
-25.0%
Q4 2022$2,768
-100.0%
440,100
-54.8%
0.00%
-60.0%
Q1 2022$8,880,000
-51.7%
974,700
+38.4%
0.01%
-56.5%
Q2 2021$18,371,000
+480.6%
704,400
+739.6%
0.02%
+666.7%
Q3 2020$3,164,000
+193.2%
83,900
+232.9%
0.00%
+200.0%
Q2 2020$1,079,00025,2000.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$11,310,44515.20%
Wildcat Capital Management, LLC 2,128,370$13,387,4475.11%
TPG GP A, LLC 18,716,306$117,725,5652.31%
EcoR1 Capital, LLC 4,488,200$28,230,7780.86%
Coastal Bridge Advisors, LLC 406,847$2,559,0680.73%
Kynam Capital Management, LP 396,378$2,493,2180.38%
AXQ CAPITAL, LP 73,052$459,4970.32%
Pier Capital, LLC 262,832$1,653,2130.27%
HARBOR CAPITAL ADVISORS, INC. 41,801$262,9280.26%
Woodline Partners LP 2,921,462$18,375,9960.25%
View complete list of ALLOGENE THERAPEUTICS INC shareholders